|
Jubilant DraxImage taps CMO
 October 17, 2012 -- Radiopharmaceutical firm Jubilant DraxImage has named Dr. Norman LaFrance as vice president, medical and regulatory affairs, and chief medical officer (CMO).
To view the remainder of this article, and other exclusive content, you must first sign-in or register using the options below.
(Helptag:PaywallArticleLoginMessage)
| |
|
|
New AuntMinnie.com Members
|
Becoming a Member is FREE!
|
Real-time radiology-specific news
Case of the Day and Teaching Files
Focused topics digital communities
Lively, discussion groups
Medical imaging bookstore
SalaryScan
Job Boards
OnLine CMe/CE
Bookstore, market reports, more …
Conference Calendar
User-controlled eNewsletters
… registration is FREE and easy!
|
| |
|
LaFrance comes to Jubilant DraxImage after stints at DuPont Merck, Bracco, Celltech, Bausch & Lomb, and Molecular Insight Pharmaceuticals. He is also the industry's representative to the U.S. Food and Drug Administration's Medical Imaging Drugs Advisory Committee (MIDAC).
In addition, LaFrance retains active medical licensure and is double board-certified in both nuclear medicine and internal medicine, Jubilant DraxImage said. | |
|